TYRO3 and plasma cell myeloma: The number of GAS6+ and MERTK+ bone marrow plasma cells (BMPCs) were significantly increased in myeloma patients compared to healthy controls; whereas AXL and TYRO3 were mainly undetectable in BMPCs of both groups and also in human myeloma cell lines.